{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T10:27:19Z","timestamp":1783247239988,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014239","name":"North Carolina Central University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014239","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejmech.2022.115055","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T11:26:14Z","timestamp":1672313174000},"page":"115055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents"],"prefix":"10.1016","volume":"248","author":[{"given":"Kavita","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Kausar","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Legac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souvik","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9779-2056","authenticated-orcid":false,"given":"Nasimul","family":"Hoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.115055_bib1","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2174\/156802611795429194","article-title":"The state of the art in anti-malarial drug discovery and development","volume":"11","author":"Burrows","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/415680a","article-title":"The economic and social burden of malaria","volume":"415","author":"Sachs","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.115055_bib3","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1172\/JCI33996","article-title":"Malaria: progress, perils, and prospects for eradication","volume":"118","author":"Greenwood","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2022.115055_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1473-3099(01)00119-0","article-title":"Modern chemotherapeutic options for malaria","volume":"1","author":"Winstanley","year":"2001","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115055_bib5","author":"WHO"},{"key":"10.1016\/j.ejmech.2022.115055_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.115055_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1475-2875-12-187","article-title":"Designing the next generation of medicines for malaria control and eradication","volume":"12","author":"Burrows","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2022.115055_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.actatropica.2005.06.009","article-title":"Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy","volume":"95","author":"Mutabingwa","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2022.115055_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.115055_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.1260403","article-title":"Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance","volume":"347","author":"Mok","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.115055_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.3189","article-title":"Genetic architecture of artemisinin-resistant Plasmodium falciparum","volume":"47","author":"Miotto","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2022.115055_bib12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1096\/fasebj.4.6.2180768","article-title":"Bifunctional thymidylate synthase\u2010dihydrofolate reductase in protozoa","volume":"4","author":"Ivanetich","year":"1990","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2022.115055_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1039\/fd9929300217","article-title":"Exploring the molecular mechanism of dihydrofolate reductase","volume":"93","author":"Brown","year":"1992","journal-title":"Faraday Discuss"},{"key":"10.1016\/j.ejmech.2022.115055_bib14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0169-4758(97)01124-1","article-title":"The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses","volume":"13","author":"Watkins","year":"1997","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.ejmech.2022.115055_bib15","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1073\/pnas.0304686101","article-title":"Gene transfer in the evolution of parasite nucleotide biosynthesis","volume":"101","author":"Striepen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2022.115055_bib16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4155\/fmc-2017-0168","article-title":"Folate biosynthesis pathway: mechanisms and insights into drug design for infectious diseases","volume":"10","author":"Bertacine Dias","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24061140","article-title":"DHFR inhibitors: reading the past for discovering novel anticancer agents","volume":"24","author":"Raimondi","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.115055_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"41","author":"Meunier","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2022.115055_bib19","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1039\/D1MD00038A","article-title":"Design, synthesis, crystal structure and anti-plasmodial evaluation of tetrahydrobenzo[4,5]thieno[2,3- d ]pyrimidine derivatives","volume":"12","author":"Pal","year":"2021","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.ejmech.2022.115055_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejmech.2016.07.035","article-title":"Computer-aided identification, synthesis and evaluation of substituted thienopyrimidines as novel inhibitors of HCV replication","volume":"123","author":"Bassetto","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejmech.2012.07.007","article-title":"Design, synthesis and biological evaluation of some novel thienopyrimidines and fused thienopyrimidines as anti-inflammatory agents","volume":"55","author":"Rizk","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejmech.2015.08.018","article-title":"Recent developments regarding the use of thieno[2,3-d]pyrimidin-4-one derivatives in medicinal chemistry, with a focus on their synthesis and anticancer properties","volume":"102","author":"Bozorov","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/00304948.2017.1320513","article-title":"Newest developments in the preparation of thieno[2,3- d ]pyrimidines","volume":"49","author":"Wilding","year":"2017","journal-title":"Org. Prep. Proced. Int."},{"key":"10.1016\/j.ejmech.2022.115055_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2012.10.007","article-title":"Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives","volume":"58","author":"Kotaiah","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib25","first-page":"439","article-title":"Synthesis and antimicrobial activity of new substituted thienopyrimidines, their tetrazolyl and sugar derivatives","volume":"69","author":"El-Sayed","year":"2021","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ejmech.2022.115055_bib26","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1016\/j.tetlet.2015.02.129","article-title":"Evolution of a thienopyrimidine antitubercular relying on medicinal chemistry and metabolomics insights","volume":"56","author":"Li","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.115055_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1039\/C4MD00441H","article-title":"Evaluation of aromatic 6-substituted thienopyrimidines as scaffolds against parasites that cause trypanosomiasis, leishmaniasis, and malaria","volume":"6","author":"Woodring","year":"2015","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2022.115055_bib28","doi-asserted-by":"crossref","first-page":"90371","DOI":"10.1039\/C6RA15181G","article-title":"Thienopyrimidine sulphonamide hybrids: design, synthesis, antiprotozoal activity and molecular docking studies","volume":"6","author":"Leeza Zaidi","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2022.115055_bib29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1021\/acsmedchemlett.8b00245","article-title":"Series of alkynyl-substituted thienopyrimidines as inhibitors of Protozoan parasite proliferation","volume":"9","author":"Woodring","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.115055_bib30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1021\/ml300091c","article-title":"Identification and in-vitro ADME assessment of a series of novel anti-malarial agents suitable for hit-to-lead chemistry","volume":"3","author":"Edlin","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.115055_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0223-5234(03)00101-6","article-title":"Synthesis and DHFR inhibitory activity of a series of 6-substituted-2,4-diaminothieno[2,3-d]pyrimidines","volume":"38","author":"Donkor","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib32","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1021\/jm900490a","article-title":"Design, synthesis, and X-ray crystal structure of classical and Nonclassical 2-Amino-4-oxo-5-substituted-6-ethylthieno[2,3- d ]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents","volume":"52","author":"Gangjee","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib33","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1021\/jm8006933","article-title":"Potent dual thymidylate synthase and dihydrofolate reductase inhibitors: classical and Nonclassical 2-Amino-4-oxo-5-arylthio-substituted-6-methylthieno[2,3- d ]pyrimidine antifolates","volume":"51","author":"Gangjee","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib34","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1021\/acs.jmedchem.8b01578","article-title":"Design, synthesis, and biological evaluation of 2-Nitroimidazopyrazin-one\/-es with antitubercular and antiparasitic activity","volume":"61","author":"Jarrad","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib35","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1039\/C5NJ03531G","article-title":"Exploiting the potential of aryl acetamide derived Zn(<scp>ii<\/scp>) complexes in medicinal chemistry: synthesis, structural analysis, assessment of biological profile and molecular docking studies","volume":"40","author":"Sultana","year":"2016","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib36","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/j.ejmech.2009.01.005","article-title":"Synthesis and in vitro trichomonicidal, giardicidal and amebicidal activity of N-acetamide(sulfonamide)-2-methyl-4-nitro-1H-imidazoles","volume":"44","author":"Hern\u00e1ndez-N\u00fa\u00f1ez","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11094-019-01951-y","article-title":"Synthesis and analgesic and anti-inflammatory activities of (3,3-dipropyl-6,7-dimethoxy-3,4-dihydroisoquinolin-1(2H)-Ylidene)-Acetamide hydrochlorides","volume":"53","author":"Yusov","year":"2019","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2022.115055_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/14756366.2011.631183","article-title":"Synthesis of new indole-2-carboxamide and 3-acetamide derivatives and evaluation their antioxidant properties","volume":"28","author":"\u00d6lgen","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib39","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/jhet.3867","article-title":"Design, synthesis, and anticancer evaluation of acetamide and hydrazine analogues of pyrimidine","volume":"57","author":"Khazir","year":"2020","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib40","doi-asserted-by":"crossref","DOI":"10.7324\/JAPS.2020.10701","article-title":"Synthesis, docking study, and pharmacological evaluation of S-acetamide derivatives of 4,6-dimethyl-2-thiopyrimidine as anticonvulsant agents","author":"Severina","year":"2020","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2022.115055_bib41","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s11094-020-02115-z","article-title":"Synthesis and analgesic, antihypoxic, and antimicrobial activity of (Z)-2-(2-Arylhydrazono)-2-(3,3-Dimethyl-3,4-Dihydroisoquinolin-1-Yl)Acetamides","volume":"53","author":"Mikhailovskii","year":"2020","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2022.115055_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112179","article-title":"Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents","volume":"192","author":"Borsoi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.118825","article-title":"Quantum chemical insight into molecular structure, NBO analysis of the hydrogen-bonded interactions, spectroscopic (FT\u2013IR, FT\u2013Raman), drug likeness and molecular docking of the novel anti COVID-19 molecule 2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluo","volume":"244","author":"Mary","year":"2021","journal-title":"Spectrochim. Acta Part A Mol Biomol Spectrosc"},{"key":"10.1016\/j.ejmech.2022.115055_bib44","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.bmc.2014.05.024","article-title":"Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain","volume":"22","author":"Sinha","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2016.04.010","article-title":"Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds","volume":"117","author":"Papadopoulou","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib46","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.1021\/jm2005546","article-title":"Optimization of propafenone analogues as antimalarial leads","volume":"54","author":"Lowes","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib47","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1021\/jm030781p","article-title":"Docking and database screening reveal new classes of Plasmodium f alciparum dihydrofolate reductase inhibitors","volume":"46","author":"Rastelli","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bmc.2008.11.021","article-title":"Search for new pharmacophores for antimalarial activity. Part I: synthesis and antimalarial activity of new 2-methyl-6-ureido-4-quinolinamides","volume":"17","author":"Madapa","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115055_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997)","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2022.115055_bib50","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.chembiol.2014.08.013","article-title":"Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates","volume":"21","author":"Doak","year":"2014","journal-title":"Chem Biol"},{"key":"10.1016\/j.ejmech.2022.115055_bib51","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1021\/jm100556b","article-title":"Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series","volume":"53","author":"Coter\u00f3n","year":"2010","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:45:39Z","timestamp":1759329939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422009576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":51,"alternative-id":["S0223523422009576"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115055","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115055"}}